Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
0(0%)
Results Posted
44%(4 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
5
45%
Ph early_phase_1
1
9%
Ph phase_2
1
9%
Ph phase_3
1
9%
Ph phase_1
3
27%

Phase Distribution

4

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 13 (27.3%)
Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 45 (45.5%)

Trials by Status

unknown19%
completed982%
terminated19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_2

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

NCT03295734
completedphase_1

Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

NCT02262780
terminatedearly_phase_1

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

NCT01804777
completedphase_4

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

NCT03115853
unknownphase_3

Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

NCT03249285
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03295734Phase 2

ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

Completed
NCT02262780Phase 1

Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

Completed
NCT01804777Early Phase 1

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Terminated
NCT03115853Phase 4

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

Completed
NCT03249285Phase 3

Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

Unknown
NCT02262858Phase 1

Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

Completed
NCT02176512Phase 1

Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects

Completed
NCT00744237Phase 4

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Completed
NCT00425997Phase 4

Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

Completed
NCT00277472Phase 4

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Completed
NCT00698646Phase 4

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11